lestaurtinib has been researched along with fascaplysine in 1 studies
| Studies (lestaurtinib) | Trials (lestaurtinib) | Recent Studies (post-2010) (lestaurtinib) | Studies (fascaplysine) | Trials (fascaplysine) | Recent Studies (post-2010) (fascaplysine) |
|---|---|---|---|---|---|
| 124 | 12 | 63 | 59 | 0 | 35 |
| Protein | Taxonomy | lestaurtinib (IC50) | fascaplysine (IC50) |
|---|---|---|---|
| Cyclin-dependent kinase 4 | Homo sapiens (human) | 0.442 | |
| G1/S-specific cyclin-D1 | Homo sapiens (human) | 0.5033 | |
| Cyclin-dependent kinase 6 | Homo sapiens (human) | 3.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bharate, SB; Sawant, SD; Singh, PP; Vishwakarma, RA | 1 |
1 review(s) available for lestaurtinib and fascaplysine
| Article | Year |
|---|---|
Kinase inhibitors of marine origin.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Aquatic Organisms; Aza Compounds; Carbazoles; Chemistry, Pharmaceutical; Depsipeptides; Furans; Humans; Indoles; Naphthyridines; Peptides, Cyclic; Phosphoinositide-3 Kinase Inhibitors; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase Inhibitors; Pyrimidines; Staurosporine; Terpenes | 2013 |